As outside and in-house counsel, provided patent preparation, prosecution, and strategic portfolio management for Lexaria Bioscience, Corp., a startup focused on enhanced delivery of lipophilic active agents, particularly cannabinoids, nicotine, NSAIDs, and vitamins. Built a worldwide patent portfolio of over 60 patent applications and 16 issued patents, enabling significant licensing activity in the cannabinoid-based food and beverage market, and strategic partnerships with Altria and British American Tobacco for reduced-risk tobacco products. Selected patent samples are provided below.